Should I buy or sell CME Group stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 2 sell ratings, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CME shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares. View CME analyst ratings or view top-rated stocks .

What is CME Group's stock price target for 2024?

9 Wall Street research analysts have issued 12 month price objectives for CME Group's shares. Their CME share price targets range from $180.00 to $240.00. On average, they expect the company's stock price to reach $213.89 in the next year. This suggests a possible upside of 4.3% from the stock's current price. View analysts price targets for CME or view top-rated stocks among Wall Street analysts .

How have CME shares performed in 2024?

CME Group's stock was trading at $210.60 at the beginning of the year. Since then, CME stock has decreased by 2.6% and is now trading at $205.09. View the best growth stocks for 2024 here .

When is CME Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 14th 2024. View our CME earnings forecast .

How can I listen to CME Group's earnings call?

CME Group will be holding an earnings conference call on Wednesday, February 14th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link .

How were CME Group's earnings last quarter?

CME Group Inc. (NASDAQ:CME) posted its quarterly earnings data on Wednesday, July, 26th. The financial services provider reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.20 by $0.10. The financial services provider earned $1.36 billion during the quarter, compared to the consensus estimate of $1.34 billion. CME Group had a net margin of 57.03% and a trailing twelve-month return on equity of 11.70%. CME Group's quarterly revenue was up 9.9% on a year-over-year basis. During the same period last year, the firm posted $1.97 EPS. Read the conference call transcript .

How often does CME Group pay dividends? What is the dividend yield for CME Group?

CME Group declared a quarterly dividend on Thursday, February 8th. Investors of record on Friday, March 8th will be given a dividend of $1.15 per share on Tuesday, March 26th. This represents a $4.60 annualized dividend and a dividend yield of 2.24%. The ex-dividend date is Thursday, March 7th. This is an increase from the stock's previous quarterly dividend of $1.10. Read our dividend analysis for CME .

Is CME Group a good dividend stock?

CME Group (NASDAQ:CME) pays an annual dividend of $4.60 per share and currently has a dividend yield of 2.15%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 54.89%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME will have a dividend payout ratio of 48.57% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CME .

What ETFs hold CME Group's stock?

ETFs with the largest weight of CME Group (NASDAQ:CME) stock in their portfolio include iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI) , Horizon Kinetics Blockchain Development ETF (BCDF) , Tema Monopolies and Oligopolies ETF (TOLL) , SmartETFs Dividend Builder ETF (DIVS) , TrueShares Low Volatility Equity Income ETF (DIVZ) , Capital Link Global Fintech Leaders ETF (KOIN) , VanEck Morningstar ESG Moat ETF (MOTE) and Amplify Transformational Data Sharing ETF (BLOK) .

What is Terry Duffy's approval rating as CME Group's CEO?

294 employees have rated CME Group Chief Executive Officer Terry Duffy on Glassdoor.com . Terry Duffy has an approval rating of 83% among the company's employees. 80.0% of employees surveyed would recommend working at CME Group to a friend.

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA) , Mastercard (MA) , PayPal (PYPL) , Walt Disney (DIS) , Visa (V) , Netflix (NFLX) , Boeing (BA) , Alibaba Group (BABA) , Cisco Systems (CSCO) and Intel (INTC) .

Who are CME Group's major shareholders?

CME Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Norges Bank (1.27%), GUARDCAP ASSET MANAGEMENT Ltd (1.10%), Fiera Capital Corp (0.96%), Raymond James & Associates (0.78%), Massachusetts Financial Services Co. MA (0.71%) and California Public Employees Retirement System (0.70%). Insiders that own company stock include Bryan T Durkin , Charles P Carey , Daniel R Glickman , Dennis Suskind , Derek Sammann , Elizabeth A Cook , Hilda Harris Piell , Howard J Siegel , Julie Holzrichter , Julie Winkler , Kathleen M Cronin , Ken Vroman , Kevin Kometer , Martin J Gepsman, Martin J Gepsman , Sean Tully , Sunil Cutinho , Terrence A Duffy , Timothy Francis Mccourt , Timothy S Bitsberger and William R Shepard . View institutional ownership trends .

How do I buy shares of CME Group?

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CME

CME Group (CME) Stock Price, News & Analysis

$205.09

+1.09 (+0.53%)

(As of 02/9/2024 08:56 PM ET)

Compare

Today's Range: $203.61
▼
$205.60
50-Day Range: $196.40
▼
$219.78
52-Week Range: $174.01
▼
$223.80

Volume: 1.71 million shs
Average Volume: 1.95 million shs
Market Capitalization: $73.83 billion

P/E Ratio: 24.47
Dividend Yield: 2.24%
Price Target: $213.89

Get CME Group alerts:

CME Group MarketRank™ Stock Analysis

Analyst Rating: Hold
2.11 Rating Score
Upside/Downside: 4.3% Upside
$213.89 Price Target
Short Interest: Healthy
1.06% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -0.26
Upright™ Environmental Score
News Sentiment: 1.14
Based on 32 Articles This Week
Insider Trading: Selling Shares
$3.97 M Sold Last Quarter
Proj. Earnings Growth: 2.49%
From $9.24 to $9.47 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.65 out of 5 stars

Finance Sector

113th out of 833 stocks

Security & Commodity Brokers, Dealers, Exchanges & Services Industry

3rd out of 9 stocks

1.1

Analyst's Opinion

Consensus Rating
CME Group has received a consensus rating of Hold. The company's average rating score is 2.11, and is based on 3 buy ratings, 4 hold ratings, and 2 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $213.89, CME Group has a forecasted upside of 4.3% from its current price of $205.09.
Amount of Analyst Coverage
CME Group has only been the subject of 3 research reports in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
1.06% of the float of CME Group has been sold short.
Short Interest Ratio / Days to Cover
CME Group has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in CME Group has recently decreased by 6.42%, indicating that investor sentiment is improving significantly.

4.2

Dividend Strength

Dividend Yield
CME Group pays a meaningful dividend of 2.15%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
CME Group has been increasing its dividend for 13 years.
Dividend Coverage
The dividend payout ratio of CME Group is 54.89%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, CME Group will have a dividend payout ratio of 48.57% next year. This indicates that CME Group will be able to sustain or increase its dividend.

2.9

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
CME Group has received a 24.21% net impact score from Upright. The largest positive contribution comes from its "Distributing knowledge" impact, which is false driven by its "Stock exchanges", "Bond exchange services", and "Derivatives exchange services" products. See details.
Environmental Sustainability
The Environmental Impact score for CME Group is -0.26.

4.0

News and Social Media Coverage

News Sentiment
CME Group has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Finance companies.
News Coverage This Week
MarketBeat has tracked 32 news articles for CME Group this week, compared to 8 articles on an average week.
Search Interest
21 people have searched for CME on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.
MarketBeat Follows
23 people have added CME Group to their MarketBeat watchlist in the last 30 days. This is an increase of 53% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CME Group insiders have sold 27,341.94% more of their company's stock than they have bought. Specifically, they have bought $14,473.00 in company stock and sold $3,971,672.00 in company stock.
Percentage Held by Insiders
Only 0.30% of the stock of CME Group is held by insiders.
Percentage Held by Institutions
85.69% of the stock of CME Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for CME Group are expected to grow by 2.49% in the coming year, from $9.24 to $9.47 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of CME Group is 24.47, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 126.07.
Price to Earnings Ratio vs. Sector
The P/E ratio of CME Group is 24.47, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 50.74.
Price to Earnings Growth Ratio
CME Group has a PEG Ratio of 2.37. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
CME Group has a P/B Ratio of 2.74. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About CME Group Stock (NASDAQ:CME)

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.

CME Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CME Stock News Headlines

February 12, 2024 | marketbeat.com

V.F. stock is a turnaround story hiding in plain sight (CME)

V.F. stock can quickly become the market's favorite turnaround play inside a sector that is on its path to an explosive breakout into expansion as well

February 7, 2024 | marketbeat.com

Analysts jumped on this stock ahead of earnings; markets love it

Simon Property Group is a REIT stock attracting lots of market - and analyst - interest to it, willing to boost targets and overpay for the underlying property

February 12, 2024 | The Oxford Club (Ad)

Multimillionaire Investor: "Hands Down the Most Lucrative Discovery of My Entire Career"

Peabody Award-winning journalist Bill Tucker sat down with a reclusive multimillionaire trader... 858 miles OUTSIDE of Wall Street... to discuss a revolutionary new trading strategy that involves...One ticker... one trade... every week.The fast-hitting profit potential is extraordinary.

February 6, 2024 | marketbeat.com

3 chemical stocks to play the industry breakout

Chemical stocks are calling for fundamental investor attention as they show a new breakout in the quarter; three stocks stand out as the best way to play it

February 5, 2024 | marketbeat.com

Markets suddenly price Eli Lilly stock for a breakout on earnings (CME)

The healthcare sector could see a sudden inflow of investment dollars, and Eli Lilly quickly becomes a favorite name in the space as markets and analysts bid up

February 5, 2024 | marketbeat.com

PayPal stock making a sudden turn, earnings breakout? (CME)

PayPal management just made the latest move to push the company's profit margins higher, widening the gap potential for the stock to catch up to the sector

February 5, 2024 | marketbeat.com

Tyson stock could see a boost in profits as costs normalize

Tyson stock could suddenly become the easiest buy for your portfolio this year; fundamental and technical factors have aligned for a new rally

January 15, 2024 | marketbeat.com

These 4 factors driving growth of young fintech stock Tradeweb (CME)

Fintech leader Tradeweb returned 14.43% in three months, fueled by financial industry growth and AI integration. Analysts see robust earnings growth ahead.

February 12, 2024 | The Oxford Club (Ad)

AI medical stock landing MASSIVE contracts

The company is tiny today, but big pharma is lining up to use its patent-protected technology. In short, it is the inventor of the world's first AI-designed drug to enter clinical trials. Currently, the stock trades for less than $10 today and is at the forefront of it all.

February 12, 2024 | americanbankingnews.com

CME Group (CME) Set to Announce Earnings on Wednesday

February 11, 2024 | finance.yahoo.com

CME Group (NASDAQ:CME) Will Pay A Dividend Of $1.15

February 8, 2024 | finance.yahoo.com

CME Group Declares Quarterly Dividend

February 7, 2024 | finance.yahoo.com

CME Group (CME) Reports Next Week: Wall Street Expects Earnings Growth

February 7, 2024 | seekingalpha.com

CME Group Q4 Earnings Preview: The Fortress In The Storm

February 7, 2024 | americanbankingnews.com

CME Group Inc. (NASDAQ:CME) to Post Q1 2024 Earnings of $2.28 Per Share, Zacks Research Forecasts

February 6, 2024 | finance.yahoo.com

3 Promising Long-Term Dividend Stocks for Steady Returns

February 6, 2024 | finance.yahoo.com

CME Group to Launch U.S. Corporate Bond Index Futures in Summer 2024

February 6, 2024 | finance.yahoo.com

Weakened commodity prices cast a shadow on farmer sentiment

February 4, 2024 | seekingalpha.com

CME Group: Uncertainty In The World Equals Higher Revenue Growth

February 2, 2024 | americanbankingnews.com

CME Group Inc. (NASDAQ:CME) Short Interest Update

February 2, 2024 | americanbankingnews.com

CME Group Inc. (NASDAQ:CME) Receives $212.30 Average PT from Brokerages

January 29, 2024 | finance.yahoo.com

CME Group Latin American FX Futures Hit All-Time Volume and Open Interest Records in 2023

January 26, 2024 | seekingalpha.com

FMX Futures Vs. CME Group - Why Copycats Fail

January 19, 2024 | ca.finance.yahoo.com

CME Jan 2024 202.500 put

January 19, 2024 | oilprice.com

Tadawul Group's Move Ignites Competition in Commodity Trading via DME Investment

January 19, 2024 | finance.yahoo.com

Here's Why CME Group (CME) Deserves a Spot in Your Portfolio

January 18, 2024 | finance.yahoo.com

Saudi Tadawul Group acquires a strategic stake in Dubai Mercantile Exchange creating Gulf Mercantile Exchange

See More Headlines

Receive CME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 7/26/2023
Ex-Dividend for 1/18 Dividend: 12/27/2023
Dividend Payable: 1/18/2024
Today: 2/11/2024
Next Earnings (Confirmed): 2/14/2024
Ex-Dividend for 3/26 Dividend: 3/07/2024
Dividend Payable: 3/26/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Finance
Industry: Security & commodity brokers, dealers, exchanges & services
Sub-Industry: Specialized Finance
Current Symbol: NASDAQ:CME
CUSIP: 12572Q10
CIK: 1156375
Web: www.cmegroup.com
Phone: (312) 930-1000
Fax: 312-466-4410
Employees: 3,460
Year Founded: 1848

Price Target and Rating

Average Stock Price Target: $213.89
High Stock Price Target: $240.00
Low Stock Price Target: $180.00
Potential Upside/Downside: +4.3%
Consensus Rating: Hold
Rating Score (0-4): 2.11
Research Coverage: 9 Analysts

Profitability

EPS (Most Recent Fiscal Year): $8.38
Trailing P/E Ratio: 24.47
Forward P/E Ratio: 22.20
P/E Growth: 2.37
Net Income: $2.69 billion
Net Margins: 57.03%
Pretax Margin: 74.33%
Return on Equity: 11.70%
Return on Assets: 2.09%

Debt

Debt-to-Equity Ratio: 0.12
Current Ratio: 1.03
Quick Ratio: 1.03

Sales & Book Value

Annual Sales: $5.35 billion
Price / Sales: 13.81
Cash Flow: $9.09 per share
Price / Cash Flow: 22.56
Book Value: $74.89 per share
Price / Book: 2.74

Miscellaneous

Outstanding Shares: 359,993,000
Free Float: 358,913,000
Market Cap: $73.83 billion
Optionable: Optionable
Beta: 0.48

Social Links

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Mr. Terrence A. Duffy (Age 66)
Chairman & CEO
Comp: $10.38M
Ms. Julie Holzrichter (Age 55)
Senior MD & COO
Comp: $1.65M
Mr. Sunil Cutinho (Age 52)
Chief Information Officer
Comp: $1.64M
Ms. Lynne Fitzpatrick (Age 45)
Chief Financial Officer
Mr. Jack Tobin (Age 60)
MD & Chief Accounting Officer
Mr. John C. Peschier (Age 56)
Managing Director of Investor Relations
Mr. Jonathan L. Marcus
Senior MD & General Counsel
Ms. Anita Liskey (Age 59)
Senior Managing Director of Corporate Marketing & Communications
Ms. Hilda Harris Piell (Age 56)
Senior MD & Chief Human Resources Officer
Mr. Kendal Vroman (Age 52)
Chief Transformation Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

Should I Buy CME Group Stock? CME Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of CME Group was last updated on Monday, January 29, 2024 at 1:31 PM.

Pros

Here are some ways that investors could benefit from investing in CME Group Inc.:

CME Group Inc. operates contract markets for the trading of futures and options on futures contracts worldwide. This provides investors with opportunities to diversify their investment portfolios and potentially generate higher returns.
CME Group Inc. has a long history, being founded in 1898. This demonstrates the company's stability and resilience in the market, which can be attractive to investors looking for established and reliable investment options.
Recent developments in CME Group Inc. have shown positive growth and performance. These developments indicate potential future growth and profitability, making it an appealing investment opportunity.
Investing in CME Group Inc. allows investors to participate in the global financial markets. This exposure can provide opportunities for capital appreciation and the ability to capitalize on market trends and fluctuations.
One interesting reason to invest in CME Group Inc. is the current stock price. Please refer to the latest stock price for more information.

Cons

Investors should be bearish about investing in CME Group Inc. for these reasons:

It's important to consider the risks associated with trading futures and options on futures contracts. These investments can be highly volatile and may result in significant financial losses.
While CME Group Inc. has a long history, past performance is not indicative of future results. Investors should carefully evaluate the company's current financial health and market conditions before making investment decisions.
The global financial markets can be unpredictable and subject to various external factors such as economic downturns, regulatory changes, and geopolitical events. These factors can impact the performance of CME Group Inc. and its investments.
Investing in CME Group Inc. may require a certain level of knowledge and expertise in trading financial derivatives. Investors should ensure they have a good understanding of the products and associated risks before investing.
It's important to consider the competitive landscape in the industry. CME Group Inc. operates in a market with other major players, and increased competition can potentially impact its market share and profitability.

CME Stock Analysis - Frequently Asked Questions

Should I buy or sell CME Group stock right now?: 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 2 sell ratings, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CME shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.
View CME analyst ratings or view top-rated stocks.
What is CME Group's stock price target for 2024?: 9 Wall Street research analysts have issued 12 month price objectives for CME Group's shares. Their CME share price targets range from $180.00 to $240.00. On average, they expect the company's stock price to reach $213.89 in the next year. This suggests a possible upside of 4.3% from the stock's current price.
View analysts price targets for CME or view top-rated stocks among Wall Street analysts.
How have CME shares performed in 2024?: CME Group's stock was trading at $210.60 at the beginning of the year. Since then, CME stock has decreased by 2.6% and is now trading at $205.09.
View the best growth stocks for 2024 here.
When is CME Group's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 14th 2024.
View our CME earnings forecast.
How can I listen to CME Group's earnings call?: CME Group will be holding an earnings conference call on Wednesday, February 14th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.
How were CME Group's earnings last quarter?: CME Group Inc. (NASDAQ:CME) posted its quarterly earnings data on Wednesday, July, 26th. The financial services provider reported $2.30 earnings per share for the quarter, beating the consensus estimate of $2.20 by $0.10. The financial services provider earned $1.36 billion during the quarter, compared to the consensus estimate of $1.34 billion. CME Group had a net margin of 57.03% and a trailing twelve-month return on equity of 11.70%. CME Group's quarterly revenue was up 9.9% on a year-over-year basis. During the same period last year, the firm posted $1.97 EPS.
Read the conference call transcript.
How often does CME Group pay dividends? What is the dividend yield for CME Group?: CME Group declared a quarterly dividend on Thursday, February 8th. Investors of record on Friday, March 8th will be given a dividend of $1.15 per share on Tuesday, March 26th. This represents a $4.60 annualized dividend and a dividend yield of 2.24%. The ex-dividend date is Thursday, March 7th. This is an increase from the stock's previous quarterly dividend of $1.10.
Read our dividend analysis for CME.

Is CME Group a good dividend stock?: CME Group (NASDAQ:CME) pays an annual dividend of $4.60 per share and currently has a dividend yield of 2.15%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 54.89%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME will have a dividend payout ratio of 48.57% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CME.
What ETFs hold CME Group's stock?: ETFs with the largest weight of CME Group (NASDAQ:CME) stock in their portfolio include iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI), Horizon Kinetics Blockchain Development ETF (BCDF), Tema Monopolies and Oligopolies ETF (TOLL), SmartETFs Dividend Builder ETF (DIVS), TrueShares Low Volatility Equity Income ETF (DIVZ), Capital Link Global Fintech Leaders ETF (KOIN), VanEck Morningstar ESG Moat ETF (MOTE) and Amplify Transformational Data Sharing ETF (BLOK).
What is Terry Duffy's approval rating as CME Group's CEO?: 294 employees have rated CME Group Chief Executive Officer Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among the company's employees. 80.0% of employees surveyed would recommend working at CME Group to a friend.
What other stocks do shareholders of CME Group own?: Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).
Who are CME Group's major shareholders?: CME Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Norges Bank (1.27%), GUARDCAP ASSET MANAGEMENT Ltd (1.10%), Fiera Capital Corp (0.96%), Raymond James & Associates (0.78%), Massachusetts Financial Services Co. MA (0.71%) and California Public Employees Retirement System (0.70%). Insiders that own company stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy Francis Mccourt, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends.
How do I buy shares of CME Group?: Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CME) was last updated on 2/12/2024 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

CME Group (CME) Stock Price, News & Analysis

CME Group MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About CME Group Stock (NASDAQ:CME)

CME Stock Price History

CME Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Insiders & Institutions

Should I Buy CME Group Stock? CME Pros and Cons Explained

Pros

Cons

CME Stock Analysis - Frequently Asked Questions

Overall MarketRank^™